
Life Sciences Equities team of Van Lanschot Kempen Investment Banking, leading in European Life Sciences. Follow us for our latest activities! | @VLKCorporate
Amsterdam, Nederland
Joined March 2012
- Tweets928
- Following213
- Followers1K
- Likes43
Van Lanschot Kempen Life Sciences retweeted
Life sciences analysts Suzanne van Voorthuizen and Alex Cogut were quoted in Dutch newspaper De Telegraaf about pricing of treatments and vaccins
telegraaf.nl/financieel/1906…
Van Lanschot Kempen Life Sciences retweeted
Life Sciences analyst Suzanne van Voorthuizen comments in Dutch newspaper @nrc about the development of a vaccine for #Covid_19: ‘Investing in vaccines is an uncertain business and not always viable.’
nrc.nl/nieuws/2020/03/20/ope…
Van Lanschot Kempen Life Sciences retweeted
The battle against cancer has raged for decades and the end game is nearing. Kempen acted as Co-Manager in #Merus’ capital increase on Nasdaq, raising USD 69m. Merus is a Dutch clinical-stage immune-oncology company.
Media requests? Call our press officer +31629713585
Van Lanschot Kempen Life Sciences retweeted
Today, our chief scientific officer, Sander van Deventer presented at the #Kempen 2019 Life Sciences conference in Amsterdam, providing an update on our progress in #Hemophilia, #Huntington’s disease and the exciting preclinical work on our research pipeline. #uniQure $QURE
Van Lanschot Kempen Life Sciences retweeted
Mats Grahn, CEO @Immunovia, hosts full day of investor meetings at Kempen Life Science Conference in Amsterdam. @KempenLS, #Kempen, #IMMray
Van Lanschot Kempen Life Sciences retweeted
We are SO proud to announce that @Morphosys has officially joined the Nasdaq family! #MorphosysIPO🎊
Van Lanschot Kempen Life Sciences retweeted
We are SO proud to announce that @Morphosys has officially joined the Nasdaq family! #MorphosysIPO🎊
Van Lanschot Kempen Life Sciences retweeted









